164 related articles for article (PubMed ID: 33891213)
1. Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation.
Köglberger P; Klein SJ; Lehner GF; Bellmann R; Peer A; Schwärzler D; Joannidis M
Ann Intensive Care; 2021 Apr; 11(1):62. PubMed ID: 33891213
[TBL] [Abstract][Full Text] [Related]
2. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
[TBL] [Abstract][Full Text] [Related]
3. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
[TBL] [Abstract][Full Text] [Related]
4. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
BMC Nephrol; 2013 Oct; 14():232. PubMed ID: 24156306
[TBL] [Abstract][Full Text] [Related]
5. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid.
Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
Hemodial Int; 2013 Apr; 17(2):313-20. PubMed ID: 22882732
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
Cassina T; Villa M; Soldani-Agnello A; Zini P
Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant effect of low concentration plasma trisodium citrate in continuous veno-venous hemofiltration.
Long J; Li Z; Zhang Z; Dong X; Zhu C
Ann Palliat Med; 2021 Aug; 10(8):8900-8908. PubMed ID: 34488377
[TBL] [Abstract][Full Text] [Related]
8. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
[TBL] [Abstract][Full Text] [Related]
9. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance.
Naka T; Egi M; Bellomo R; Cole L; French C; Wan L; Fealy N; Baldwin I
Int J Artif Organs; 2005 Mar; 28(3):222-8. PubMed ID: 15818544
[TBL] [Abstract][Full Text] [Related]
10. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury.
Liu DL; Huang LF; Ma WL; Ding Q; Han Y; Zheng Y; Li WX
Chin Med J (Engl); 2016 Jul; 129(14):1682-7. PubMed ID: 27411455
[TBL] [Abstract][Full Text] [Related]
11. The acid-base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration.
Egi M; Naka T; Bellomo R; Langenberg CC; Li W; Fealy N; Baldwin I
Int J Artif Organs; 2008 Mar; 31(3):228-36. PubMed ID: 18373316
[TBL] [Abstract][Full Text] [Related]
12. Citrate anticoagulation during CVVH in high risk bleeding patients.
Cubattoli L; Teruzzi M; Cormio M; Lampati L; Pesenti A
Int J Artif Organs; 2007 Mar; 30(3):244-52. PubMed ID: 17417764
[TBL] [Abstract][Full Text] [Related]
13. Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution.
Jeffrey YH; Hoi-Ping S; Kit Hung AL; Chung-Ling L; Wing-Wa Y; King-Yiu L
Indian J Crit Care Med; 2017 Jan; 21(1):11-16. PubMed ID: 28197045
[TBL] [Abstract][Full Text] [Related]
14. Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration.
Jacobs R; Honore PM; Diltoer M; Spapen HD
BMC Nephrol; 2016 Aug; 17(1):119. PubMed ID: 27562561
[TBL] [Abstract][Full Text] [Related]
15. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
Ong SC; Wille KM; Speer R; Tolwani AJ
Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
[TBL] [Abstract][Full Text] [Related]
16. Impact of continuous veno-venous hemofiltration on acid-base balance.
Rocktäschel J; Morimatsu H; Uchino S; Ronco C; Bellomo R
Int J Artif Organs; 2003 Jan; 26(1):19-25. PubMed ID: 12602465
[TBL] [Abstract][Full Text] [Related]
17. A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration.
Egi M; Naka T; Bellomo R; Cole L; French C; Trethewy C; Wan L; Langenberg CC; Fealy N; Baldwin I
Int J Artif Organs; 2005 Dec; 28(12):1211-8. PubMed ID: 16404696
[TBL] [Abstract][Full Text] [Related]
18. Biochemical effects of phosphate-containing replacement fluid for continuous venovenous hemofiltration.
Chua HR; Baldwin I; Ho L; Collins A; Allsep H; Bellomo R
Blood Purif; 2012; 34(3-4):306-12. PubMed ID: 23235269
[TBL] [Abstract][Full Text] [Related]
19. Crush syndrome after the Wenchuan earthquake: new experience with regional citrate anticoagulation continuous veno-venous hemofiltration.
Xie HL; Ji DX; Hu WX; Wu Y; Ge YC; Hou JH; Li LS; Liu ZH
Int J Artif Organs; 2010 Feb; 33(2):114-22. PubMed ID: 20306438
[TBL] [Abstract][Full Text] [Related]
20. Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study.
Bianchi NA; Altarelli M; Eckert P; Schneider AG
Blood Purif; 2020; 49(5):567-575. PubMed ID: 32126564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
